The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Throughout the month of September, several cancer therapies were approved by the Food and Drug Administration (FDA) for diseases including breast cancer, multiple myeloma, non-small cell lung cancer ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Under current FDA guidance, a compounded drug cannot be “essentially a copy of an approved drug,” unless it meets an exemption (e.g., appearing on the drug shortage list). Essentially a copy ...

It’s called Cobenfy, and it’s the first new drug for the mental health condition to be successfully developed in over 70 years. Cobenfy, now FDA-approved ... the drug’s list price, before ...

How to maximize your results with weight loss pills For you to achieve the best results from weight loss pills, it’s important to use them in conjunction with a balanced diet, regular exercise ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on Thursday approved the ... “A lower list price might make the therapy ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...